Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10308644 Heterocyclic compounds as immunomodulators

Patent 10308644 was granted and assigned to Incyte on June, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Incyte
Incyte
0
Date Filed
December 21, 2017
0
Date of Patent
June 4, 2019
0
Patent Applicant
Incyte
Incyte
0
Patent Application Number
15850170
0
Patent Citations Received
‌
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same
‌
US Patent 11472791 Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
‌
US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same
‌
US Patent 12024517 Salts of an FGFR inhibitor
0
‌
US Patent 12059470 Formulated and/or co-formulated liposome compositions containing PD-1 antagonist prodrugs useful in the treatment of cancer and methods thereof
0
‌
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
‌
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
‌
US Patent 12084443 Process of preparing a PD-1/PD-L1 inhibitor
0
‌
US Patent 11465981 Heterocyclic compounds as immunomodulators
•••
Patent Inventor Names
Liangxing Wu
0
Wenqing Yao
0
Jingwei Li
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10308644
0
Patent Primary Examiner
‌
Samantha L Shterengarts
0

Find more entities like US Patent 10308644 Heterocyclic compounds as immunomodulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo